nach oben

Erschienen in:

30.06.2022 | Original Article

Huntington’s disease and neurovascular structure of retina

verfasst von: Elahe Amini, Mehdi Moghaddasi, Seyed Amir Hassan Habibi, Zahra Azad, Shahnaz Miri, Naveed Nilforushan, Reza Mirshahi, Esther Cubo, Nahid Mohammadzadeh, Mohammad Rohani

Erschienen in: Neurological Sciences | Ausgabe 10/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

Retinal biomarkers in neurodegenerative disorders have attracted much attention in recent years. Recent studies have reported visual dysfunction in Huntington’s disease (HD). However, little is known about retinal structural changes in HD.

Methods

A total of 50 subjects, including 25 motor-manifest HD patients and 25 gender- and age-matched controls, were enrolled. Unified Huntington’s Disease Rating Score-Motor part was assessed in HD patients. Spectral-domain Optical Coherence Tomography (SD-OCT) was used to evaluate the macular thickness and peripapillary retinal nerve fiber layer (pRNFL). Superficial and deep capillary plexus densities were measured using OCT angiography (OCTA). To account for inter-eye correlation, generalized estimating equation (GEE) model was used.

Results

HD patients had a significant reduction in macular thickness in both inner and outer superior sectors and the inferior outer sector. Inferior pRNFLs were significantly decreased in thickness. There was no significant difference in retinal capillary plexus density between the two groups. Age and disease duration were negatively correlated with macular thickness in HD patients. However, the severity of motor involvement was not correlated with SD-OCT or OCTA parameters.

Conclusions

We observed attenuated pRNFL and macular retinal thickness in patients with HD, independent of macular capillary plexus parameters. It can support the hypothesis that the retina may be a potential biomarker for monitoring the neurodegenerative process in HD.

Nur mit Berechtigung zugänglich

Roos RA (2010) Huntington’s disease: a clinical review. Orphanet J Rare Dis 5(1):1–8. https://doi.org/10.1186/1750-1172-5-40CrossRef

Andrade C, Beato J, Monteiro A, Costa A, Penas S, Guimarães J, Reis FF, Garrett C (2016) Spectral-domain optical coherence tomography as a potential biomarker in Huntington’s disease. Mov Disord 31(3):377–383. https://doi.org/10.1002/mds.26486CrossRefPubMed

Di Maio LG, Montorio D, Peluso S, Dolce P, Salvatore E, De Michele G, Cennamo G (2021) Optical coherence tomography angiography findings in Huntington’s disease. Neurol Sci 42(3):995–1001. https://doi.org/10.1007/s10072-020-04611-2CrossRefPubMed

Kersten HM, Danesh-Meyer HV, Kilfoyle DH, Roxburgh RH (2015) Optical coherence tomography findings in Huntington’s disease: a potential biomarker of disease progression. J Neurol 262(11):2457–2465. https://doi.org/10.1007/s00415-015-7869-2CrossRefPubMed

Gatto E, Parisi V, Persi G, Fernandez Rey E, Cesarini M, Luis Etcheverry J, Rivera P, Squitieri F (2018) Optical coherence tomography (OCT) study in Argentinean Huntington’s disease patients. Int J Neurosci 128(12):1157–1162. https://doi.org/10.1080/00207454.2018.1489807CrossRefPubMed

Mason SL, Barker RA (2016) Novel targets for Huntington’s disease: future prospects. Degener Neurol Neuromuscul Dis 6:25. https://doi.org/10.2147/DNND.S83808CrossRefPubMedPubMedCentral

Ha AD, Fung VS (2012) Huntington’s disease. Curr Opin Neurol 25(4):491–498. https://doi.org/10.1097/WCO.0b013e3283550c97CrossRefPubMed

Crair MC, Mason CA (2016) Reconnecting eye to brain. J Neurosci 36(42):10707–10722. https://doi.org/10.1523/JNEUROSCI.1711-16.2016CrossRefPubMedPubMedCentral

Trost A, Lange S, Schroedl F, Bruckner D, Motloch KA, Bogner B, Kaser-Eichberger A, Strohmaier C, Runge C, Aigner L (2016) Brain and retinal pericytes: origin, function and role. Front Cell Neurosci 10:20. https://doi.org/10.3389/fncel.2016.00020CrossRefPubMedPubMedCentral

10.

Doustar J, Torbati T, Black KL, Koronyo Y, Koronyo-Hamaoui M (2017) Optical coherence tomography in Alzheimer’s disease and other neurodegenerative diseases. Front Neurol 8:701. https://doi.org/10.3389/fneur.2017.00701CrossRefPubMedPubMedCentral

11.

Moinuddin O, Khandwala NS, Young KZ, Sathrasala SK, Barmada SJ, Albin RL, Besirli CG (2021) Role of optical coherence tomography in identifying retinal biomarkers in frontotemporal dementia: a review. Neurol Clin Pract 11(4):e516–e523. https://doi.org/10.1212/CPJ.0000000000001041CrossRefPubMedPubMedCentral

12.

Sengupta P, Dutta K, Ghosh S, Mukherjee A, Pal S, Basu D (2018) Optical coherence tomography findings in patients of Parkinson’s disease an Indian perspective. Ann Indian Acad Neurol 21(2):150. https://doi.org/10.4103/aian.AIAN_152_18CrossRefPubMedPubMedCentral

13.

Abd Hamid MR, Hitam W-HW, Abd Halim S (2021) Retinal nerve fiber layer and macular thickness in Parkinson’s disease patients. Cureus 13(7):e16224. https://doi.org/10.7759/cureus.16224CrossRefPubMedPubMedCentral

14.

Schneider M, Müller H-P, Lauda F, Tumani H, Ludolph AC, Kassubek J, Pinkhardt EH, Retinal single-layer analysis in Parkinsonian syndromes (2014) an optical coherence tomography study. J Neural Transm 121(1):41–47. https://doi.org/10.1007/s00702-013-1072-3CrossRefPubMed

15.

Chan VT, Sun Z, Tang S, Chen LJ, Wong A, Tham CC, Wong TY, Chen C, Ikram MK, Whitson HE (2019) Spectral-domain OCT measurements in Alzheimer’s disease: a systematic review and meta-analysis. Ophthalmology 126(4):497–510. https://doi.org/10.1016/j.ophtha.2018.08.009CrossRefPubMed

16.

Dhalla A, Pallikadavath S, Hutchinson CV (2019) Visual dysfunction in Huntington’s disease: a systematic review. J Huntingtons Dis 8(2):233–242. https://doi.org/10.3233/JHD-180340CrossRefPubMed

17.

Hui J, Zhao Y, Yu S, Liu J, Chiu K, Wang Y (2021) Detection of retinal changes with optical coherence tomography angiography in mild cognitive impairment and Alzheimer’s disease patients: a meta-analysis. PLoS ONE 16(8):e0255362. https://doi.org/10.1371/journal.pone.0255362CrossRefPubMedPubMedCentral

18.

Tsokolas G, Tsaousis KT, Diakonis VF, Matsou A, Tyradellis S (2020) Optical coherence tomography angiography in neurodegenerative diseases: a review. Eye Brain 12:73. https://doi.org/10.2147/EB.S193026CrossRefPubMedPubMedCentral

19.

Siesling S, van Vugt JP, Zwinderman KA, Kieburtz K, Roos RA (1998) Unified Huntington’s disease rating scale: a follow up. Mov Disord 13(6):915–919. https://doi.org/10.1002/mds.870130609CrossRefPubMed

20.

Ghasemi Falavarjani K, Mirshahi R, Ghasemizadeh S, Sardarinia M (2020) Stepwise segmentation error correction in optical coherence tomography angiography images of patients with diabetic macular edema. Ther Adv Ophthalmol 27:12. https://doi.org/10.1177/2515841420947931CrossRef

21.

Zou J, Liu K, Li F, Xu Y, Shen L, Xu H (2020) Combination of optical coherence tomography (OCT) and OCT angiography increases diagnostic efficacy of Parkinson’s disease. Quant Imaging Med Surg 10(10):1930. https://doi.org/10.21037/qims-20-460CrossRefPubMedPubMedCentral

22.

Sevim DG, Unlu M, Gultekin M, Karaca C (2019) Retinal single-layer analysis with optical coherence tomography shows inner retinal layer thinning in Huntington’s disease as a potential biomarker. Int Ophthalmol 39(3):611–621. https://doi.org/10.1007/s10792-018-0857-7CrossRef

23.

Parisi V, Restuccia R, Fattapposta F, Mina C, Bucci MG, Pierelli F (2001) Morphological and functional retinal impairment in Alzheimer’s disease patients. Clin Neurophysiol 112(10):1860–1867. https://doi.org/10.1016/S1388-2457(01)00620-4CrossRefPubMed

24.

Lu Y, Li Z, Zhang X, Ming B, Jia J, Wang R, Ma D (2010) Retinal nerve fiber layer structure abnormalities in early Alzheimer’s disease: evidence in optical coherence tomography. Neurosci Lett 480(1):69–72. https://doi.org/10.1016/j.neulet.2010.06.006CrossRefPubMed

25.

Kesler A, Vakhapova V, Korczyn AD, Naftaliev E, Neudorfer M (2011) Retinal thickness in patients with mild cognitive impairment and Alzheimer’s disease. Clin Neurol Neurosurg 113(7):523–526. https://doi.org/10.1016/j.clineuro.2011.02.014CrossRefPubMed

26.

Chi Y, Wang Y-h, Yang L (2010) The investigation of retinal nerve fiber loss in Alzheimer’s disease. [Zhonghua yan ke za zhi] Chinese J Ophthalmol 46(2):134–139

27.

Kromer R, Serbecic N, Hausner L, Aboul-Enein F, Froelich L, Beutelspacher S (2014) Detection of retinal nerve fiber layer defects in Alzheimer’s disease using SD-OCT. Front Psych 5:22. https://doi.org/10.3389/fpsyt.2014.00022CrossRef

28.

Zabel P, Kałużny JJ, Wiłkość-Dębczyńska M, Gębska-Tołoczko M, Suwała K, Kucharski R, Araszkiewicz A (2019) Peripapillary retinal nerve fiber layer thickness in patients with Alzheimer’s disease: a comparison of eyes of patients with Alzheimer’s disease, primary open-angle glaucoma, and preperimetric glaucoma and healthy controls. Med Sci Monit 25:1001. https://doi.org/10.12659/MSM.914889CrossRefPubMedPubMedCentral

29.

Yu J-G, Feng Y-F, Xiang Y, Huang J-H, Savini G, Parisi V, Yang W-J, Fu X-A (2014) Retinal nerve fiber layer thickness changes in Parkinson disease: a meta-analysis. PLoS ONE 9(1):e85718. https://doi.org/10.1371/journal.pone.0085718CrossRefPubMedPubMedCentral

30.

Rohani M, Langroodi AS, Ghourchian S, Falavarjani KG, SoUdi R, Shahidi G (2013) Retinal nerve changes in patients with tremor dominant and akinetic rigid Parkinson’s disease. Neurol Sci 34(5):689–693. https://doi.org/10.1007/s10072-012-1125-7CrossRefPubMed

31.

Birkeldh U, Manouchehrinia A, Hietala MA, Hillert J, Olsson T, Piehl F, Kockum IS, Brundin L, Zahavi O, Wahlberg-Ramsay M (2017) The temporal retinal nerve fiber layer thickness is the most important optical coherence tomography estimate in multiple sclerosis. Front Neurol 8:675. https://doi.org/10.3389/fneur.2017.00675CrossRefPubMedPubMedCentral

32.

Gómez-Esteban JC, Lezcano E, Zarranz JJ, Velasco F, Garamendi I, Pérez T, Tijero B (2007) Monozygotic twins suffering from Huntington’s disease show different cognitive and behavioural symptoms. Eur Neurol 57(1):26–30. https://doi.org/10.1159/000097006CrossRefPubMed

33.

Georgiou N, Bradshaw JL, Chiu E, Tudor A, O’Gorman L, Phillips JG (1999) Differential clinical and motor control function in a pair of monozygotic twins with Huntington’s disease. Mov Disord 14(2):320–325. https://doi.org/10.1002/1531-8257(199903)14:2%3c320::AID-MDS1018%3e3.0.CO;2-ZCrossRefPubMed

34.

Ferrari L, Huang S-C, Magnani G, Ambrosi A, Comi G, Leocani L (2017) Optical coherence tomography reveals retinal neuroaxonal thinning in frontotemporal dementia as in Alzheimer’s disease. J Alzheimers Dis 56(3):1101–1107. https://doi.org/10.3233/JAD-160886CrossRefPubMed

35.

Chan ST, Mercaldo ND, Kwong KK, Hersch SM, Rosas HD (2021) Impaired cerebrovascular reactivity in Huntington’s disease. Front Physiol 12:663898. https://doi.org/10.3389/fphys.2021.663898CrossRefPubMedPubMedCentral

36.

Bodis-Wollner I (2013) Foveal vision is impaired in Parkinson’s disease. Parkinsonism Relat Disord 19(1):1–14. https://doi.org/10.1016/j.parkreldis.2012.07.012CrossRefPubMed

37.

Polo V, Rodrigo MJ, Garcia-Martin E, Otin S, Larrosa JM, Fuertes MI, Bambo MP, Pablo LE, Satue M (2017) Visual dysfunction and its correlation with retinal changes in patients with Alzheimer’s disease. Eye (Lond) 31(7):1034–1041. https://doi.org/10.1038/eye.2017.23CrossRef

38.

Nanetti L, Contarino VE, Castaldo A, Sarro L, Bachoud-Levi A-C, Giavazzi M, Frittoli S, Ciammola A, Rizzo E, Gellera C (2018) Cortical thickness, stance control, and arithmetic skill: an exploratory study in premanifest Huntington disease. Parkinsonism Relat Disord 51:17–23. https://doi.org/10.1016/j.parkreldis.2018.02.033CrossRefPubMed

39.

Odish O, Reijntjes R, van den Bogaard S, Roos R, Leemans A (2018) Progressive microstructural changes of the occipital cortex in Huntington’s disease. Brain Imaging Behav 12(6):1786–1794. https://doi.org/10.1007/s11682-018-9849-5CrossRefPubMedPubMedCentral

40.

Johnson EB, Rees EM, Labuschagne I, Durr A, Leavitt BR, Roos RA, Reilmann R, Johnson H, Hobbs NZ, Langbehn DR (2015) The impact of occipital lobe cortical thickness on cognitive task performance: an investigation in Huntington’s disease. Neuropsychologia 79:138–146. https://doi.org/10.1016/j.neuropsychologia.2015.10.033CrossRefPubMed

Titel: Huntington’s disease and neurovascular structure of retina
verfasst von: Elahe Amini
Mehdi Moghaddasi
Seyed Amir Hassan Habibi
Zahra Azad
Shahnaz Miri
Naveed Nilforushan
Reza Mirshahi
Esther Cubo
Nahid Mohammadzadeh
Mohammad Rohani
Publikationsdatum: 30.06.2022
Verlag: Springer International Publishing
Erschienen in: Neurological Sciences / Ausgabe 10/2022
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-022-06232-3

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Background

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2022

Steroid-induced central serous chorioretinopathy in neuromyelitis optica spectrum disorders: a case report

The Janus faces of SARS-COV-2 infection in myasthenia gravis and myasthenic crisis

Ulnar neuropathy at elbow with uncommon neurophysiological findings. When the neurophysiology is not clear

Tremor-like grasp phenomenon: case series study

Safety and efficacy of melatonin, clonazepam, and trazodone in patients with Parkinson’s disease and sleep disorders: a randomized, double-blind trial